Interstitial Lung Disease Following Osimertinib Initiation in Lung Cancer with Miliary Pulmonary Metastases: a Case Report
Haigan · 20.04.2026 · 66 (2) · 83-90
DOI: 10.2482/haigan.66.83 ↗Kurz gefasst
Fallbericht in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Hidenori Takahashi und 14 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Miliary pulmonary metastases are rare but enriched for EGFR mutations; in patients who are not candidates for a tissue biopsy, a plasma liquid biopsy is clinically useful. However, EGFR tyrosine kinase inhibitor (TKI)-associated interstitial lung disease (ILD) can be life-threatening. Case. The patient was an 88-year-old woman (cT4N2M1c) with suspected miliary pulmonary metastases and carcinomatous lymphangitis could not undergo an invasive biopsy. A plasma liquid biopsy identified an EGFR L858R mutation, and osimertinib (80 mg/day) was initiated. Ten days after starting osimertinib, she developed respiratory failure with bilateral ground-glass opacities and was diagnosed with diffuse alveolar damage (DAD)-pattern ILD. After discontinuation of the culprit drug and initiation of systemic corticosteroids, her condition rapidly improved.
Conclusions
In our review of 39 cases of osimertinib-related ILD including the present case, 11 patients showed the DAD pattern, which-despite its greater severity-was generally responsive to steroids. As the liquid biopsy-guided initiation of TKI therapy becomes more common in biopsy-ineligible patients, stringent early monitoring is essential, particularly in high-risk cases.
Zitieren
APA
Takahashi, H., Toyama-Kosaka, M., Yasuda, T., Taguchi, K., Yoshizawa, G., Furukawa, K., Satake, Y., Nagamatsu, H., Hirose, R., Toba, N., Ota, S., Morikawa, M., Kanno, Y., Makino, T., & Shinkai, M. (2026). Interstitial Lung Disease Following Osimertinib Initiation in Lung Cancer with Miliary Pulmonary Metastases: a Case Report. Haigan, 66(2), 83-90. https://doi.org/10.2482/haigan.66.83
Vancouver
Takahashi H, Toyama-Kosaka M, Yasuda T, Taguchi K, Yoshizawa G, Furukawa K, et al. Interstitial Lung Disease Following Osimertinib Initiation in Lung Cancer with Miliary Pulmonary Metastases: a Case Report. Haigan. 2026;66(2):83-90. doi:10.2482/haigan.66.83
BibTeX
@article{Takahashi2026,
author = {Takahashi, Hidenori and Toyama-Kosaka, Mio and Yasuda, Takumi and Taguchi, Kota and Yoshizawa, Go and Furukawa, Kanako and Satake, Yugo and Nagamatsu, Hiroki and Hirose, Ryutaro and Toba, Naoya and Ota, Shinichiro and Morikawa, Miwa and Kanno, Yasunari and Makino, Takashi and Shinkai, Masaharu},
title = {Interstitial Lung Disease Following Osimertinib Initiation in Lung Cancer with Miliary Pulmonary Metastases: a Case Report},
journal = {Haigan},
year = {2026},
volume = {66},
number = {2},
pages = {83--90},
doi = {10.2482/haigan.66.83}
}
EUVIMED